• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of clinical neuromuscular disease >Satisfactory Response With Achieving Maintenance Low-Dose Prednisone in Generalized Myasthenia Gravis
【24h】

Satisfactory Response With Achieving Maintenance Low-Dose Prednisone in Generalized Myasthenia Gravis

机译：令人满意的反应在普通肌肌肌肌肌肌腱中达到维护低剂量泼尼松

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objectives:To estimate the satisfactory response rate (SR%) with achieving maintenance, low-dose prednisone in acetylcholine receptor antibody-positive generalized myasthenia gravis.Methods:In this retrospective study, we estimate the SR% as defined by (remission/minimal manifestations status for at least 6 months vising 7.5 nig or less of prednisone daily, for maintenance treatment at 2, 4, and 6 years after symptoms onset) for patients who were not taking steroid-sparing immunosup-pressant (SSI) as a primary outcome and for patients taking an SSI as a secondary outcome.Results:Forty-five patients were not taking an SSI at 2 years, 34 patients at 4 years, and 17 patients at 6 years; SR % was 44.4%, 64/7%, and 58.8%, respectively. Thirty-six patients were taking an SSI at 2 years, 22 patients at 4 years, and 15 patients at 6 years; the SR% was 50.0%, 45.4%, and 66.7%, respectively.Conclusions:Nearly half of the generalized myasthenia gravis patients who were not taking an SSI achieved an SR.
机译：目的：估计乙酰胆碱受体抗体阳性抗体抗体阳性肌肌肌肌肌肌肌肌肌肌肌肌肌肌肌肌肌肌肌肌肌肌肌肌肌肌肌肌孢子中的令人满意的反应率（SR％）。 8个月的状态为每天参加7.5个Nig或更少的泼尼松，用于在症状后的2,4和6年的维持治疗，用于未服用类固醇滥本免疫压制（SSI）作为主要结果的患者为患有SSI作为次要结果的患者。结果：4岁以下的患者未服用SSI，34例患者4岁，6岁患者6岁; SR％分别为44.4％，64/7％和58.8％。三十六名患者在2岁时服用SSI，22例患者4岁，6例患者6岁; SR％分别为50.0％，45.4％和66.7％。结论：近一半的一半不采取SSI的肌醇患者达到了SS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号